English Overview
This webinar will give context around Alopecia Areata, and discuss the Olumiant as the new and only JAKi approved for the indication
This Activity for
- Resident / Fellow
- Physician
What I will learn?
Establish that AA is an autoimmune condition with a high impact on patient quality of life, beyond hair loss.
Discuss the limitations of current therapies
Learn about the MOA of Olumiant in AA, its efficacy and safety data in patients with severe AA
How to initiate and monitor patients on Olumiant.
Discuss the limitations of current therapies
Learn about the MOA of Olumiant in AA, its efficacy and safety data in patients with severe AA
How to initiate and monitor patients on Olumiant.
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
A New Treatment Option in Alopecia Areata Certificate
Certificate |
Certificate | Free |
VAT 15% Included
